Real-World Efficacy of Bezlotoxumab for Prevention of Recurrent Clostridium Difficile Infection: A Retrospective Study of 46 Patients in Five University Hospitals in Finland
European Journal of Clinical Microbiology and Infectious Diseases - Germany
doi 10.1007/s10096-019-03630-y
Full Text
Open PDFAbstract
Available in full text
Date
July 29, 2019
Authors
Publisher
Springer Science and Business Media LLC